Sepio Capital’s Elevance Health ELV Stock Holding History

Sepio Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Buy	+610	New	+$226K	0.01%	317
2026 Q1	–	Sell	-573	Closed	-$201K	–	384
2025 Q4	$201K	Buy	+573	New	+$194K	0.01%	352
2023 Q2	–	Sell	-5,219	Closed	-$2.4M	–	344
2023 Q1	$2.4M	Buy	5,219 +176	+3%	+$83.8K	0.22%	131
2022 Q4	$2.59M	Buy	+5,043	New	+$2.56M	0.22%	115
2022 Q1	–	Sell	-9,429	Closed	-$4.37M	–	358
2021 Q4	$4.37M	Sell	9,429 -3,294	-26%	-$1.39M	0.32%	92
2021 Q3	$4.74M	Buy	12,723 +1,818	+17%	+$691K	0.39%	70
2021 Q2	$4.16M	Buy	+10,905	New	+$4.17M	0.34%	83

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sepio Capital's ELV Position: Q2 2026 in Review

Sepio Capital opened a new position in Elevance Health (ELV) in Q2 2026: 610 shares worth $236K. The stake represents 0.01% of the portfolio and ranks #317 among its holdings. This is a return to the name: Sepio Capital previously reported a position in ELV as recently as Q4 2025.

Sepio Capital first reported a position in ELV in Q2 2021 and has held it in 7 quarters since. The position peaked at $4.74M in Q3 2021. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Sepio Capital held 610 shares of Elevance Health worth $236K as of Q2 2026.
Elevance Health was a new Sepio Capital position in Q2 2026.
Elevance Health made up 0.01% of Sepio Capital's portfolio in Q2 2026, its #317 holding.
Sepio Capital first reported a position in Elevance Health in Q2 2021 and has held it in 7 quarters since.
Sepio Capital's Elevance Health position peaked at $4.74M in Q3 2021.
1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.